We made the match!
THANK YOU to all the Vasalgel supporters who stepped up to meet the $5,000 one-day challenge last week. One of Vasalgel’s biggest supporters — a
THANK YOU to all the Vasalgel supporters who stepped up to meet the $5,000 one-day challenge last week. One of Vasalgel’s biggest supporters — a
We’re making the clinical trial batch of Vasalgel this month! And we need your help! Parsemus Foundation is a small organization that’s determined to provide
If you’ve been following Vasalgel for some time, you already know that this new, long-acting contraceptive worked well in rabbits. But now it’s official! The
A key goal for the first Vasalgel studies, in addition to demonstrating the contraceptive’s safety and effectiveness, was to establish its reversibility. Vasalgel was reversible
With a year of animal efficacy studies done on Vasalgel male contraceptive, we’ve demonstrated its feasibility — and it’s time to build momentum! But it
A LOT of men (and their partners) are waiting eagerly for news of the clinical trials of Vasalgel. It’s getting closer! Over the next six
World Vasectomy Day is an educational event to promote greater understanding and participation by men in family planning. A number of educational events took place on
A history of male contraceptive development – as experienced and related by our founder Elaine Lissner – was recently covered in a Priceonomics article called “The
The Telegraph announced that only one in 10 British men would take a male birth control pill when it is available. This finding is opposite
The Medical Daily published a comprehensive news article on the development of male contraceptives, highlighting Vasalgel’s journey to market. Journalist Stephanie Castillo interviewed Parsemus Foundation’s
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: